These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31217965)

  • 61. Safety pharmacology studies using EFP and impedance.
    Obergrussberger A; Juhasz K; Thomas U; Stölzle-Feix S; Becker N; Dörr L; Beckler M; Bot C; George M; Fertig N
    J Pharmacol Toxicol Methods; 2016; 81():223-32. PubMed ID: 27084108
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Electrophysiological evaluation of pentamidine and 17-AAG in human stem cell-derived cardiomyocytes for safety assessment.
    Asahi Y; Nomura F; Abe Y; Doi M; Sakakura T; Takasuna K; Yasuda K
    Eur J Pharmacol; 2019 Jan; 842():221-230. PubMed ID: 30391349
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Contribution of potassium channels to action potential repolarization of human embryonic stem cell-derived cardiomyocytes.
    Wang Y; Zhu R; Tung L
    Br J Pharmacol; 2019 Aug; 176(15):2780-2794. PubMed ID: 31074016
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of the cardiotoxicity of mitragynine and its analogues using human induced pluripotent stem cell-derived cardiomyocytes.
    Lu J; Wei H; Wu J; Jamil MF; Tan ML; Adenan MI; Wong P; Shim W
    PLoS One; 2014; 9(12):e115648. PubMed ID: 25535742
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Selective block of IKs plays a significant role in MAP triangulation induced by IKr block in isolated rabbit heart.
    Guérard NC; Traebert M; Suter W; Dumotier BM
    J Pharmacol Toxicol Methods; 2008; 58(1):32-40. PubMed ID: 18582585
    [TBL] [Abstract][Full Text] [Related]  

  • 66. BACE1 modulates gating of KCNQ1 (Kv7.1) and cardiac delayed rectifier KCNQ1/KCNE1 (IKs).
    Agsten M; Hessler S; Lehnert S; Volk T; Rittger A; Hartmann S; Raab C; Kim DY; Groemer TW; Schwake M; Alzheimer C; Huth T
    J Mol Cell Cardiol; 2015 Dec; 89(Pt B):335-48. PubMed ID: 26454161
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mechanisms of gefitinib-induced QT prolongation.
    Jie LJ; Li YD; Zhang HQ; Mao L; Xie HB; Zhou FG; Zhou TL; Xie D; Lin JL; Li GY; Cai BN; Zhang YH; Wang Y
    Eur J Pharmacol; 2021 Nov; 910():174441. PubMed ID: 34474028
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Subunit interaction determines IKs participation in cardiac repolarization and repolarization reserve.
    Silva J; Rudy Y
    Circulation; 2005 Sep; 112(10):1384-91. PubMed ID: 16129795
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Development of a Patient-Specific p.D85N-Potassium Voltage-Gated Channel Subfamily E Member 1-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for Drug-Induced Long QT Syndrome.
    Kim M; Ye D; John Kim CS; Zhou W; Tester DJ; Giudicessi JR; Ackerman MJ
    Circ Genom Precis Med; 2021 Jun; 14(3):e003234. PubMed ID: 34003017
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Repolarization reserve determines drug responses in human pluripotent stem cell derived cardiomyocytes.
    Braam SR; Tertoolen L; Casini S; Matsa E; Lu HR; Teisman A; Passier R; Denning C; Gallacher DJ; Towart R; Mummery CL
    Stem Cell Res; 2013 Jan; 10(1):48-56. PubMed ID: 23089628
    [TBL] [Abstract][Full Text] [Related]  

  • 71. HIV-Tat induces a decrease in I
    Es-Salah-Lamoureux Z; Jouni M; Malak OA; Belbachir N; Al Sayed ZR; Gandon-Renard M; Lamirault G; Gauthier C; Baró I; Charpentier F; Zibara K; Lemarchand P; Beaumelle B; Gaborit N; Loussouarn G
    J Mol Cell Cardiol; 2016 Oct; 99():1-13. PubMed ID: 27590098
    [TBL] [Abstract][Full Text] [Related]  

  • 72. CSAHi study: Evaluation of multi-electrode array in combination with human iPS cell-derived cardiomyocytes to predict drug-induced QT prolongation and arrhythmia--effects of 7 reference compounds at 10 facilities.
    Kitaguchi T; Moriyama Y; Taniguchi T; Ojima A; Ando H; Uda T; Otabe K; Oguchi M; Shimizu S; Saito H; Morita M; Toratani A; Asayama M; Yamamoto W; Matsumoto E; Saji D; Ohnaka H; Tanaka K; Washio I; Miyamoto N
    J Pharmacol Toxicol Methods; 2016; 78():93-102. PubMed ID: 26657830
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cells.
    Jehle J; Ficker E; Wan X; Deschenes I; Kisselbach J; Wiedmann F; Staudacher I; Schmidt C; Schweizer PA; Becker R; Katus HA; Thomas D
    Br J Pharmacol; 2013 Mar; 168(5):1215-29. PubMed ID: 23061993
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Role of somatic cell sources in the maturation degree of human induced pluripotent stem cell-derived cardiomyocytes.
    Pianezzi E; Altomare C; Bolis S; Balbi C; Torre T; Rinaldi A; Camici GG; Barile L; Vassalli G
    Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118538. PubMed ID: 31472168
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Overexpression of KCNJ2 in induced pluripotent stem cell-derived cardiomyocytes for the assessment of QT-prolonging drugs.
    Li M; Kanda Y; Ashihara T; Sasano T; Nakai Y; Kodama M; Hayashi E; Sekino Y; Furukawa T; Kurokawa J
    J Pharmacol Sci; 2017 Jun; 134(2):75-85. PubMed ID: 28615142
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ion Channel Expression and Characterization in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Zhao Z; Lan H; El-Battrawy I; Li X; Buljubasic F; Sattler K; Yücel G; Lang S; Tiburcy M; Zimmermann WH; Cyganek L; Utikal J; Wieland T; Borggrefe M; Zhou XB; Akin I
    Stem Cells Int; 2018; 2018():6067096. PubMed ID: 29535773
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dexmedetomidine exhibits antiarrhythmic effects on human-induced pluripotent stem cell-derived cardiomyocytes through a Na/Ca channel-mediated mechanism.
    Yang L; Gong Y; Tan Y; Wu L; Witman N; Zheng J; Zhang J; Fu W; Wang W
    Ann Transl Med; 2021 Mar; 9(5):399. PubMed ID: 33842620
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Eag Domains Regulate LQT Mutant hERG Channels in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Liu QN; Trudeau MC
    PLoS One; 2015; 10(4):e0123951. PubMed ID: 25923442
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Re-trafficking of hERG reverses long QT syndrome 2 phenotype in human iPS-derived cardiomyocytes.
    Mehta A; Sequiera GL; Ramachandra CJ; Sudibyo Y; Chung Y; Sheng J; Wong KY; Tan TH; Wong P; Liew R; Shim W
    Cardiovasc Res; 2014 Jun; 102(3):497-506. PubMed ID: 24623279
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Patient-Specific Human Induced Pluripotent Stem Cell Model Assessed with Electrical Pacing Validates S107 as a Potential Therapeutic Agent for Catecholaminergic Polymorphic Ventricular Tachycardia.
    Sasaki K; Makiyama T; Yoshida Y; Wuriyanghai Y; Kamakura T; Nishiuchi S; Hayano M; Harita T; Yamamoto Y; Kohjitani H; Hirose S; Chen J; Kawamura M; Ohno S; Itoh H; Takeuchi A; Matsuoka S; Miura M; Sumitomo N; Horie M; Yamanaka S; Kimura T
    PLoS One; 2016; 11(10):e0164795. PubMed ID: 27764147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.